Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

A tablet of ivermectin. The U.S. Food and Drug Administration warned Americans against taking ivermectin, a drug usually used on animals, as a treatment or prevention for Covid-19. Photo: Dimas Ardian/Bloomberg via Getty Images

Prescriptions for Ivermectin soared more than 70% between 2019 and the beginning of 2021, according to insurance claim data compiled by Komodo Health.

Why it matters: Ivermectin — which has some dermatological uses in humans but is mostly for veterinary purposes — has not been shown to be at all effective against COVID, yet its use has soared, fueled in part by rampant misinformation.

What they're saying: "We’re doing an insurance claims analysis — providers are writing those prescriptions and pharmacists are filling them," Tabby Khan, Komodo's medical director, told Axios.

  • "It's like: How deep does this disinformation go that it's now impacting providers?"

By the numbers: The greatest increases were seen in Idaho, New Mexico, and Wyoming, where the prescriptions increased by 258%, 216%, and 204%, respectively.

  • The latest installment of the Axios/Ipsos Coronavirus Index found the majority (65%) of respondents had either never heard of Ivermectin or said it was a dangerous or ineffective treatment for treating COVID in humans.
  • But 10% said they believed it was safe and effective for treating COVID in humans.

The intrigue: The Komodo data appears to illuminate, in many settings, a backdoor for patients to obtain the drug for off-label use.

  • Prescriptions from dermatologists, the specialty that has traditionally been the most likely to recommend the drug, rose only 2% during the study time period.
  • At the same time, prescriptions for the drug from doctors in anesthesiology, physical medicine and rehabilitation, and pulmonary disease specialties increased 1,319%, 1,301%, and 1,167%, respectively. 

The bottom line: "This is just a small pot of the Ivermectin being taken in the United States right now, because for every physician and insurance claim that gets filed, you'll also see people going to animal supply stores or paying out of pocket. This is really concerning," Khan said.

Methodology: This Axios/Ipsos Poll was conducted Sept. 24–27 by Ipsos' KnowledgePanel®. This poll is based on a nationally representative probability sample of 1,105 general population adults age 18 or older.

  • The margin of sampling error is ±3.2 percentage points at the 95% confidence level, for results based on the entire sample of adults.

Go deeper

11 hours ago - Health

CDC: Unvaccinated are over 11 times more likely to die from COVID

Expand chart
Reproduced from CDC; Note: Data represents 30% of Americans across 16 jurisdictions: Alabama, Arizona, Arkansas, Colorado, Connecticut, Florida, Georgia, Idaho, Louisiana, Massachusetts, Michigan, Nebraska, New Mexico, New York City, Seattle/King County, Wash., Utah and Wisconsin; Chart: Danielle Alberti/Axios

The CDC recently published data evaluating Americans' rate of coronavirus cases and deaths by vaccine status, providing more data on which vaccines are working best and how much protection they offer relative to being unvaccinated.

What they found: As of August, unvaccinated people had a more than six times higher risk of testing positive for the coronavirus, and were more than 11 times more likely to die from the virus.

Oct 17, 2021 - Health

Fauci: J&J recipients will likely be able to mix and match boosters

Anthony Fauci. Photo: Stefani Reynolds-Pool/Getty Images

The Food and Drug Administration and Centers for Disease Control and Prevention will likely allow recipients of the Johnson & Johnson COVID-19 to mix and match vaccine boosters depending on their individual health, NIAID director Anthony Fauci told ABC News' '"This Week" on Sunday.

Why it matters: The FDA's vaccine expert panel on Friday unanimously endorsed booster shots for adult recipients of the J&J vaccine. The panel is also exploring the mix and match strategy but hasn't yet taken a formal vote on the matter.

Updated 8 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Vaccines: Mix-and-matching gains momentum — Boosters overtake first doses in U.S. — Pfizer to vaccinate Brazilian cityPanel endorses J&J booster.
  2. Health: Unvaccinated 11x more likely to die from COVID — 5x more police officers died from COVID than guns — New cases down
  3. Politics: Over 30 states limited public health powers — Pope Francis calls on companies to release COVID vaccine patents — Melbourne, "world's most locked-down city," to lift stay-at-home orders.
  4. Education: Education secretary reveals limits to Biden’s mask push on states — LA extends deadline for school employee vaccinations — Parent sues Wisconsin school district after child tests positive.
  5. Variant tracker: Where different strains are spreading.